FdaApplication
ANDA 212925
Identifiers
- fda_app_no: ANDA212925
Properties
| Property | Value |
|---|---|
| applicant_name | PANGEA PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-12-09 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CELECOXIB | CELECOXIB | 200MG | CAPSULE;ORAL |
| CELECOXIB | CELECOXIB | 400MG | CAPSULE;ORAL |
2 products